Understanding how axolotls regenerate their eye lenses
Elucidation of cellular reprogramming processes that drive lens regeneration in axolotl as a basis for future therapeutic approaches
['FUNDING_OTHER'] · UNIVERSITY OF NEW HAMPSHIRE · NIH-11003673
This study is looking at how axolotls and newts can heal their eye lenses after getting hurt, and it aims to learn more about the special cells that help them do this, which could eventually lead to new treatments for people with similar eye problems.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF NEW HAMPSHIRE (nih funded) |
| Locations | 1 site (DURHAM, UNITED STATES) |
| Trial ID | NIH-11003673 on ClinicalTrials.gov |
What this research studies
This research investigates the unique ability of axolotls and newts to regenerate their eye lenses after injury. By studying the iris pigmented epithelial (IPE) cells, which can activate, proliferate, and reprogram to form new lens tissue, the researchers aim to uncover the molecular mechanisms behind this regeneration. The study employs advanced techniques like transcriptomics and flow cytometry to identify specific cell populations involved in this process. Insights gained could pave the way for new regenerative therapies in humans.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals suffering from age-related macular degeneration or other conditions affecting lens regeneration.
Not a fit: Patients with irreversible lens damage or those who do not have conditions related to lens regeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative treatments for lens-related blindness and other ocular conditions in humans.
How similar studies have performed: While the regeneration of ocular tissues in salamanders is well-documented, this specific approach to understanding the underlying mechanisms is novel and has not been extensively tested in humans.
Where this research is happening
DURHAM, UNITED STATES
- UNIVERSITY OF NEW HAMPSHIRE — DURHAM, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: SOUSOUNIS, KONSTANTINOS — UNIVERSITY OF NEW HAMPSHIRE
- Study coordinator: SOUSOUNIS, KONSTANTINOS
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: age related macular disease